A carregar...
Benign Presentation Following Massive Deutetrabenazine Overdose
Deutetrabenazine (DTBZ) (Austedo®) is a novel vesicular monoamine transporter 2 (VMAT2) inhibitor, which acts by blocking dopamine release and other monoamines from neuronal vesicles. Although this drug is considered the first-line treatment for tardive dyskinesia (TD), VMAT2 inhibition has also bee...
Na minha lista:
| Publicado no: | Cureus |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cureus
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7899254/ https://ncbi.nlm.nih.gov/pubmed/33633914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.12886 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|